224 related articles for article (PubMed ID: 14515339)
21. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia.
Raiteri M; Bonanno G; Vallebuona F
J Pharmacol Exp Ther; 1995 May; 273(2):643-9. PubMed ID: 7752066
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase C and dopamine transport--2. Effects of amphetamine in vitro.
Giambalvo CT
Neuropharmacology; 1992 Dec; 31(12):1211-22. PubMed ID: 1361666
[TBL] [Abstract][Full Text] [Related]
23. Evidence of an exocytotic-like release of [3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes.
Gobbi M; Frittoli E; Uslenghi A; Mennini T
Eur J Pharmacol; 1993 Jul; 238(1):9-17. PubMed ID: 8405087
[TBL] [Abstract][Full Text] [Related]
24. Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin.
Suyama JA; Sakloth F; Kolanos R; Glennon RA; Lazenka MF; Negus SS; Banks ML
J Pharmacol Exp Ther; 2016 Jan; 356(1):182-90. PubMed ID: 26645638
[TBL] [Abstract][Full Text] [Related]
25. Fluoxetine-induced inhibition of synaptosomal [3H]5-HT release: possible Ca(2+)-channel inhibition.
Stauderman KA; Gandhi VC; Jones DJ
Life Sci; 1992; 50(26):2125-38. PubMed ID: 1608295
[TBL] [Abstract][Full Text] [Related]
26. Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil.
Ferraro L; Fuxe K; Tanganelli S; Fernandez M; Rambert FA; Antonelli T
Neuropharmacology; 2000 Aug; 39(11):1974-83. PubMed ID: 10963741
[TBL] [Abstract][Full Text] [Related]
27. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
Johnson GJ; Leis LA; Dunlop PC; Weir EK
J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103
[TBL] [Abstract][Full Text] [Related]
28. The promiscuity of the dopamine transporter: implications for the kinetic analysis of [3H]serotonin uptake in rat hippocampal and striatal synaptosomes.
Norrholm SD; Horton DB; Dwoskin LP
Neuropharmacology; 2007 Dec; 53(8):982-9. PubMed ID: 18022203
[TBL] [Abstract][Full Text] [Related]
29. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
Mitchell SN; Greenslade RG; Cooper J
Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
[TBL] [Abstract][Full Text] [Related]
30. The nature of d,l-fenfluramine-induced 5-HT reuptake transporter loss in rats.
Westphalen RI; Dodd PR
Mol Neurobiol; 1995; 11(1-3):165-75. PubMed ID: 8561960
[TBL] [Abstract][Full Text] [Related]
31. Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism.
Bonanno G; Fassio A; Severi P; Ruelle A; Raiteri M
J Neurochem; 1994 Sep; 63(3):1163-6. PubMed ID: 8051559
[TBL] [Abstract][Full Text] [Related]
32. Effects of antidepressant drug combinations on cortical 5-HT2 receptors and wet-dog shakes in rats.
Koshikawa F; Koshikawa N; Stephenson JD
Eur J Pharmacol; 1985 Dec; 118(3):273-81. PubMed ID: 2935412
[TBL] [Abstract][Full Text] [Related]
33. Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release.
Smith RL; Gresch PJ; Barrett RJ; Sanders-Bush E
Pharmacol Biochem Behav; 2002 May; 72(1-2):77-85. PubMed ID: 11900772
[TBL] [Abstract][Full Text] [Related]
34. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats.
Gobbi M; Crespi D; Foddi MC; Fracasso C; Mancini L; Parotti L; Mennini T
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):22-8. PubMed ID: 9228186
[TBL] [Abstract][Full Text] [Related]
35. Further evidence of Ca(2+)-dependent, exocytotic-like serotonin release induced by D-fenfluramine.
Cinquanta M; Frittoli E; Mennini T; Gobbi M
Pharmacol Res; 1997 May; 35(5):439-42. PubMed ID: 9299208
[TBL] [Abstract][Full Text] [Related]
36. The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists.
Fletcher PJ; Sinyard J; Higgins GA
Psychopharmacology (Berl); 2006 Sep; 187(4):515-25. PubMed ID: 16832658
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
38. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism.
Fornal C; Radulovacki M
J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135
[TBL] [Abstract][Full Text] [Related]
39. Effects of subchronic pretreatment with D-fenfluramine or p-chloroamphetamine on [3H]inositolmonophosphate accumulation in rat cortical miniprisms.
Erfurth A; Gardier AM; Ribeiro E; Wurtman RJ
Brain Res; 1994 Nov; 665(1):107-14. PubMed ID: 7882002
[TBL] [Abstract][Full Text] [Related]
40. Antagonism of fenfluramine-induced hyperthermia in rats by some, but not all, selective inhibitors of 5-hydroxytryptamine uptake.
Sugrue MF
Br J Pharmacol; 1984 Apr; 81(4):651-7. PubMed ID: 6722394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
